113 related articles for article (PubMed ID: 35090205)
21. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study of postoperative adjuvant radiotherapy and postoperative concurrent chemoradiotherapy for locally advanced hypopharyngeal squamous cell carcinoma].
Liu K; Zhang XX; Liu MB; Wang JL; Wu WM; Huang DL; Zhao JD; Ma L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 54(9):662-669. PubMed ID: 31550757
[No Abstract] [Full Text] [Related]
23. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation.
Liu WS; Hsin CH; Chou YH; Liu JT; Wu MF; Tseng SW; Lee JK; Tseng HC; Wang TH; Su MC; Lee H
BMC Cancer; 2010 Mar; 10():102. PubMed ID: 20298550
[TBL] [Abstract][Full Text] [Related]
25. Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy.
Watanabe S; Ogino I; Inayama Y; Sugiura M; Sakuma Y; Kokawa A; Kunisaki C; Inoue T
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e3-e10. PubMed ID: 25359448
[TBL] [Abstract][Full Text] [Related]
26. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
[TBL] [Abstract][Full Text] [Related]
27. Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.
Paximadis P; Yoo G; Lin HS; Jacobs J; Sukari A; Dyson G; Christensen M; Kim H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1515-21. PubMed ID: 21658855
[TBL] [Abstract][Full Text] [Related]
28. [A single-arm prospective study on induction chemotherapy and subsequent comprehensive therapy for advanced hypopharyngeal squamous cell carcinoma: report of 260 cases in a single center].
Yang YF; Wang R; Fang JG; Zhong Q; Huang ZG; Chen XH; Zhang SR; Gao JM; Li SL; Li PD; Hou LZ; Chen XJ; Ma HZ; Feng L; Zhang Y; He SZ; Lian M; Liu SZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Dec; 55(12):1143-1153. PubMed ID: 33342130
[No Abstract] [Full Text] [Related]
29. [The results and toxicity of organ preservation treatment for locoregionally advanced laryngeal and hypopharyngeal cancer].
Kiprian D; Kawecki A; Jarząbski A; Michalski W; Pawłowska-Sendułka B
Otolaryngol Pol; 2011; 65(5):363-8. PubMed ID: 22078287
[TBL] [Abstract][Full Text] [Related]
30. [The clinical characteristics and treatment outcomes of 386 patients with hypopharyngeal cancer].
Cao YT; Zhou L; Wu HT; Li XM; Huang WT; Chen XL; Li C; Tao L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):433-9. PubMed ID: 27345879
[TBL] [Abstract][Full Text] [Related]
31. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics of 97 hypopharyngeal carcinoma cases].
Lian X; Ji W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Mar; 29(6):542-6. PubMed ID: 26211163
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with gastrostomy tube dependence after concurrent chemoradiotherapy for hypopharyngeal cancer.
Murono S; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Support Care Cancer; 2015 Feb; 23(2):457-62. PubMed ID: 25129396
[TBL] [Abstract][Full Text] [Related]
34. [Clinical analysis of multimodal treatment for orbital organ preservation in T4b squamous cell carcinoma of nasal cavity and paranasal sinuses].
Chen NX; Zhang XX; Chen L; Wang JL; Yan F; Ma L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):497-503. PubMed ID: 27480297
[TBL] [Abstract][Full Text] [Related]
35. Intensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancer.
Huang WY; Jen YM; Chen CM; Su YF; Lin CS; Lin YS; Chang YN; Chao HL; Lin KT; Chang LP
Radiat Oncol; 2010 May; 5():37. PubMed ID: 20470428
[TBL] [Abstract][Full Text] [Related]
36. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
[TBL] [Abstract][Full Text] [Related]
37. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association.
Morse E; Berson E; Fujiwara R; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):267-276. PubMed ID: 30324861
[TBL] [Abstract][Full Text] [Related]
38. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
39. [Effect of vascular changes on prognosis after induced chemotherapy for advanced hypopharyngeal carcinoma].
Guo W; Yin GF; Huang JW; Yang Z; Liu HF; Zhang Y; Xu HB; Liu ZY; Huang ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):591-596. PubMed ID: 31434372
[No Abstract] [Full Text] [Related]
40. Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.
Tangsriwong K; Jitreetat T
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2051-2057. PubMed ID: 31350965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
